Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3418-3426

  Arakawa, Tetsuji ^a   Masaki, Takao ^a   Hirai, Takayuki ^a   Doi, Shigehiro ^a   Kuratsune, Masatoshi ^a   Arihiro, Koji ^b   Kohno, Nobuoki ^a   Yorioka, Noriaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cell proliferation; Glomerulonephritis; Renal injury; STAT3

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLINE; IMMUNOSUPPRESSIVE AGENT; STAT3 PROTEIN; STEROID;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STAINING; STEROID THERAPY; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; CELL PROLIFERATION; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULITIS; YOUNG ADULT;

EID: 54149110149     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn314     Document Type: Article

References (23)

1. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421
2. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178: 2623-2629
3. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264: 95-98
4. Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 2007; 13: 1362-1366
5. Levy DE, Lee CK. What does Stat3 do? J Clin Invest 2002; 109: 1143-1148
6. Amiri F, Shaw S, Wang X et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 2002; 61: 1605-1616
7. Wang X, Shaw S, Amiri F et al. Inhibition of the JAK/STAT signaling pathway prevents the high glucose-induced increase in TGF-b and fibronectin synthesis in mesangial cells. Diabetes 2002; 51: 3505-3509
8. Lee YJ, Heo JS, Suh HN et al. Interleukin-6 stimulates a-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-kB. Am J Physiol Renal Physiol 2007; 293: F1036-F1046
9. Huang JS, Chuang LY, Guh JY et al. Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells. Am J Physiol Renal Physiol 2007; 293: F1072-F1082
10. Arany I, Megyesi JK, Nelkin BD et al. STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney Int 2006; 70: 669-674
11. Yanagita M, Arai H, Nakano T et al. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J Biol Chem 2001; 276: 42364-42369
12. Zhang W, Chen X, Shi S et al. Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril. Nephrol Dial Transplant 2005; 20: 892-901
13. Banes AK, Shaw S, Jenkins J et al. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. Am J Physiol Renal Physiol 2004; 286: F653-F659
14. Yang N, Luo M, Li R et al. Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrol Dial Transplant 2008; 23: 91-100
15. Kuratsune M, Masaki T, Hirai T et al. Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction. Nephrology (Carlton) 2007; 12: 565-571
16. Hirai T, Masaki T, Kuratsune M et al. PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation. Clin Exp Immunol 2006; 144: 353-361
17. Lan HY, Mu W, Nikolic-Paterson DJ et al. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 1995; 43: 97-102
18. Couser WG. Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 1998; 13(Suppl 1): 10-15
19. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995; 26: 124-132
20. Zeisberg M, Strutz F, Müller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 2000; 13(Suppl 3): S111-S120
21. Nightingale J, Patel S, Suzuki N et al. Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol 2004; 15: 21-32
22. Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 2001; 16(Suppl 5): 3-7
23. Niemand C, Nimmesgern A, Haan S et al. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003; 170: 32633272